Clinical Trial Update: Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC [NA]

View source ↗

Summary

The document reports a clinical trial examining radiofrequency ablation with sorafenib for early to intermediate hepatocellular carcinoma. The trial status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Southwest Hospital, China | Conditions: HCC | NA | Status: UNKNOWN